SLXNW
Silexion Therapeutics Warrant
SLXNW
SLXNW
25 hedge funds and large institutions have $199K invested in Silexion Therapeutics Warrant in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Holders
25
Holding in Top 10
–
Calls
$17K
Puts
–
Top Buyers
| 1 | +$3.63K | |
| 2 | +$2.92K | |
| 3 | +$2.33K | |
| 4 |
Goldman Sachs
New York
|
+$200 |
Top Sellers
| 1 | -$1.19K | |
| 2 | -$799 | |
| 3 | -$456 | |
| 4 |
HP
Hartree Partners
New York
|
-$412 |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$394 |
